Source: REBusinessOnline

Alcresta : Alcresta Therapeutics Signs 14,441 SF Life Sciences Lease in Waltham, Massachusetts

WALTHAM, MASS. - Alcresta Therapeutics, which develops enzyme-based treatments for rare diseases, has signed a 14,441-square-foot life sciences lease at 130 Turner Street, a 270,000-square-foot facility located in the western [...] The post Alcresta Therapeutics Signs 14,441 SF Life Sciences Lease in Waltham, Massachusetts appeared first on REBusinessOnline.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Daniel Orlando's photo - Chairman & CEO of Alcresta

Chairman & CEO

Daniel Orlando

CEO Approval Rating

90/100

Read more